Watson Jones, D., Changalucha, J., Whitworth, H., Pinto, L., Mutani, P., Indangasi, J., . . . Baisley, K. (2022). Immunogenicity and safety of one-dose human papillomavirus vaccine compared with two or three doses in Tanzanian girls (DoRIS): An open-label, randomised, non-inferiority trial.
Citación estilo ChicagoWatson Jones, Deborah, et al. Immunogenicity and Safety of One-dose Human Papillomavirus Vaccine Compared With Two or Three Doses in Tanzanian Girls (DoRIS): An Open-label, Randomised, Non-inferiority Trial. 2022.
Cita MLAWatson Jones, Deborah, et al. Immunogenicity and Safety of One-dose Human Papillomavirus Vaccine Compared With Two or Three Doses in Tanzanian Girls (DoRIS): An Open-label, Randomised, Non-inferiority Trial. 2022.